Sulthiame shows promise in reducing obstructive sleep apnea symptoms

Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnoea (OSA), according to results of a clinical trial presented at the European Respiratory Society (ERS) Congress in Vienna, Austria.

Opinion | From D-Day to Assassination Attempts: Where Medicine and History Intertwine

Baum is a urologist. Twice over the course of this summer I have been glued to the TV by breaking news coverage of the global

September 5, 2024

New insights into the role of gamma-delta T cells across 33 cancer types revealed

A new study published in Cell Press reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their

October 4, 2024

CitiusTech Launches Generative AI Quality & Trust Solution

What You Should Know: – CitiusTech, a healthcare technology provider, has unveiled a groundbreaking solution to address the reliability, quality, and trust concerns surrounding Generative

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.